DYK that disease progression modeling (DPM) can improve trial efficiency, clarify uncertainty & support precision medicine? Join #CTTI on 7/8 @ noon EDT for a free webinar launching new recs on using DPM in medical product development. bit.ly/3ZoQFGy

Today is the last day to complete the survey for #CTTI’s workshop on #AI in Drug and Biological Product Development. Your input will help shape this year’s agenda: bit.ly/4jCWiIu

Heading to #DIA2025? Join #CTTI’s Morgan Hanger on 6/18 for “Building Upon Quality by Design and Risk-Based Monitoring Implementation Momentum.” New case studies. Real solutions. Practical tools to drive adoption + impact. #clinicaltrials #QbD

Can flexible trials still deliver high-quality data? 🤔 Join us at #DIA2025 on June 18 for, “Do Flexible Trial Approaches Impede Data Quality?” #CTTI’s Lindsay Kehoe leads the convo with U.S. FDA, NIH & Florence Healthcare. Let’s bust some myths. 💥

Still hitting roadblocks with #QbD and Risk-Based Monitoring? Hear fresh case studies and solutions from #CTTI’s Morgan Hanger & experts at #DIA2025 this Wednesday!

#Decentralized #clinicaltrials. Embedded research. Adjusted settings. What do they really mean for data quality? Find out tomorrow at #DIA2025 with #CTTI’s Lindsay Kehoe + experts from U.S. FDA, NIH & Florence Healthcare.

#CTTI’s Watchtower project is assessing #clinicaltrial site readiness in the U.S. to better respond to public health emergencies. Learn how we’re working to rapidly expand research capacity in times of urgent need: bit.ly/44kvet1

🚨 Join us on 6/24 at the 2025 Roundtable on Ethics, Trust + Patient Centricity in Pharma, hosted by Bioethics Intl, EY, Yale University, & Scientific American! #CTTI's Morgan Hanger speaks on transparency & ethics in #clinicaltrials.

#CTTI’s Watchtower project is creating a framework to evaluate U.S. #clinicaltrial site readiness— helping to support faster, more coordinated research during future public health emergencies. Learn more: bit.ly/44kvet1

How do we define trustworthy pharma in 2025? Tomorrow #CTTI’s Morgan Hanger will moderate a small group at the 2025 Ethics & Pharma Roundtable—driving bold ideas on metrics for transparency, trust & patient-first R&D. Don’t miss it!

From expert meetings to reviewing infrastructure mapping projects, #CTTI’s Watchtower project is gathering the data needed to improve trial site readiness nationwide. Learn how: bit.ly/44kvet1

#CTTI’s Watchtower project is developing tools to assess and enhance U.S. #clinicaltrial site capacity—supporting a faster, more unified research response when the next public health emergency strikes. Learn more: bit.ly/44kvet1

🎬 Missed the inaugural State of Clinical Trials meeting? Watch the highlight video to see how 150 leaders are shaping the future of research—together. From patient-centricity to policy shifts, the momentum is real. bit.ly/SOCThighlights

TMRW: Join #CTTI @ noon EDT for a free webinar unveiling new recs on when & how to use disease progression modeling (DPM) in medical product development. bit.ly/3ZoQFGy

Flexibility ≠ lower data quality. At #DIA2025, #CTTI led a panel unpacking how #decentralized, patient-centric #clinicaltrials can enhance data integrity — when guided by Quality by Design. More from the conversation: bit.ly/44E39vS

Free webinar today @ noon EDT! #CTTI is launching new recs on disease progression modeling (DPM) with keynote speaker Cynthia J. Musante from @Pfizer. Learn how DPM can support smarter, more efficient decision making. bit.ly/4nDIAZ4

The recording of #CTTI’s webinar on disease progression modeling is now available. Hear expert insights and explore the recommendations & considerations framework to guide thoughtful use of #DPM in clinical development. bit.ly/460j361

How can disease progression modeling support better trial design and decision making? Watch #CTTI’s webinar and explore the recommendations and considerations framework for practical guidance. #DPM bit.ly/460j361

Today #CTTI honors the life of Phil Green, who turned his #ALS diagnosis into a mission to improve #clinicaltrials for all. His leadership, empathy & work with CTTI helped drive more patient-centered, accessible research. His legacy lives on. 🧡 bit.ly/green-phil

🎥 Why Now, Why Us: Answering the Call to Transform #ClinicalTrials What inspired leaders from across the research ecosystem to attend the #StateOfClinicalTrials? Hear their “why” in this powerful new video from #CTTI. ▶️ Watch now: bit.ly/3HlK1uU